미국 · 보도자료 · ALTERITY THERAPEUTICS LIMITED · 2026-10-09 11:05
캐너코드 제뉴이티 의약품·의료기기 콘퍼런스 참가 발표
MELBOURNE, Australia and SAN FRANCISCO, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M.D., Chief Executive Officer, will present at the Canaccord Genuity Drug and Device Conference on Mond
ALTERITY THERAPEUTICS LIMITED 다른 공시·급등 이유 보기 · GK의 공시레이더 — 미국·한국 실시간 공시
